DK2094734T3 - Polysaccharider derivatiseret med citronsyre - Google Patents

Polysaccharider derivatiseret med citronsyre

Info

Publication number
DK2094734T3
DK2094734T3 DK07859099.9T DK07859099T DK2094734T3 DK 2094734 T3 DK2094734 T3 DK 2094734T3 DK 07859099 T DK07859099 T DK 07859099T DK 2094734 T3 DK2094734 T3 DK 2094734T3
Authority
DK
Denmark
Prior art keywords
citric acid
polysaccharides
oligo
alkaline
residue
Prior art date
Application number
DK07859099.9T
Other languages
Danish (da)
English (en)
Inventor
Marco Bosco
Luca Stucchi
Fabrizio Picotti
Rita Gianni
Original Assignee
Sigea Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigea Srl filed Critical Sigea Srl
Application granted granted Critical
Publication of DK2094734T3 publication Critical patent/DK2094734T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B31/00—Preparation of derivatives of starch
    • C08B31/02—Esters
    • C08B31/04—Esters of organic acids, e.g. alkenyl-succinated starch
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/731—Cellulose; Quaternized cellulose derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/732—Starch; Amylose; Amylopectin; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/736—Chitin; Chitosan; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B3/00—Preparation of cellulose esters of organic acids
    • C08B3/12—Preparation of cellulose esters of organic acids of polybasic organic acids
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B33/00—Preparation of derivatives of amylose
    • C08B33/02—Esters
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0018—Pullulan, i.e. (alpha-1,4)(alpha-1,6)-D-glucan; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • C08B37/0027—2-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
    • C08B37/003—Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0036—Galactans; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0084—Guluromannuronans, e.g. alginic acid, i.e. D-mannuronic acid and D-guluronic acid units linked with alternating alpha- and beta-1,4-glycosidic bonds; Derivatives thereof, e.g. alginates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK07859099.9T 2006-12-29 2007-12-18 Polysaccharider derivatiseret med citronsyre DK2094734T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06425873A EP1939219A1 (en) 2006-12-29 2006-12-29 Polysaccharides derivatised with citric acid
PCT/IB2007/003980 WO2008081257A2 (en) 2006-12-29 2007-12-18 Polysaccharides derivatised with citric acid

Publications (1)

Publication Number Publication Date
DK2094734T3 true DK2094734T3 (da) 2010-11-15

Family

ID=37964263

Family Applications (1)

Application Number Title Priority Date Filing Date
DK07859099.9T DK2094734T3 (da) 2006-12-29 2007-12-18 Polysaccharider derivatiseret med citronsyre

Country Status (13)

Country Link
US (1) US8629252B2 (enExample)
EP (2) EP1939219A1 (enExample)
JP (1) JP5372774B2 (enExample)
AT (1) ATE481425T1 (enExample)
AU (1) AU2007341080A1 (enExample)
CA (1) CA2673953A1 (enExample)
DE (1) DE602007009306D1 (enExample)
DK (1) DK2094734T3 (enExample)
ES (1) ES2348215T3 (enExample)
PL (1) PL2094734T3 (enExample)
PT (1) PT2094734E (enExample)
SI (1) SI2094734T1 (enExample)
WO (1) WO2008081257A2 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8841440B2 (en) * 2008-04-01 2014-09-23 Cornell University Organo-soluble chitosan salts and chitosan-derived biomaterials prepared thereof
DE102010012183A1 (de) * 2010-03-19 2011-09-22 Fresenius Medical Care Deutschland Gmbh Veresterte Polysaccharid-Osmotika
CN102492057B (zh) * 2011-12-15 2013-07-10 石狮市华宝海洋生物化工有限公司 一种超高密度壳聚糖的制备方法
US8697843B1 (en) 2013-02-08 2014-04-15 The United States Of America, As Represented By The Secretary Of Agriculture Superabsorbant materials from chemically modified gluten
BR112016021768B1 (pt) 2014-03-25 2021-08-31 Basf Se Éster de carboxilato de polissacarídeo, seu método de preparo, solução aquosa, composição para limpeza de roupas, pó e composição detergente para lavagem automática de louça compreendendo o mesmo
KR20170016386A (ko) * 2014-06-02 2017-02-13 테티스, 아이엔씨. 개질된 생체중합체, 및 이의 제조 및 사용 방법
US10689566B2 (en) 2015-11-23 2020-06-23 Anavo Technologies, Llc Coated particles and methods of making and using the same
WO2018087272A1 (en) * 2016-11-11 2018-05-17 Anteis S.A. Hyaluronic acid dermal fillers crosslinked with citric acid, method for making same and uses thereof
WO2019110106A1 (de) 2017-12-07 2019-06-13 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Verfahren zur vernetzung von polymeren mit nucleophilen funktionalitäten, vernetzte polymere sowie verwendungen hiervon
JP7905194B2 (ja) * 2022-03-25 2026-08-14 群栄化学工業株式会社 ３次元積層造形物の製造方法、及び３次元積層造形用キット

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2486803A (en) * 1946-06-14 1949-11-01 Henry H Frede & Company Inc Absorbent fibrous sheets and method of making same
US2664397A (en) * 1947-09-16 1953-12-29 Phillips Petroleum Co Ion-exchange resins from carboxyalkyl cellulose ethers
US2759787A (en) * 1953-05-15 1956-08-21 Eastman Kodak Co Cellulose citrates and their preparation
US3097051A (en) * 1958-11-18 1963-07-09 Ricardo H Wade Cellulose ester anhydrides in fiber form
GB1229527A (enExample) * 1968-12-12 1971-04-21 Warner Lambert Pharmaceutical
DK354479A (da) * 1978-10-11 1980-04-12 Pfizer Carboxylerede celluose-ion-byttematerialer fremgangsmaade til deres fremstilling samt deres anvendelse til fjernelse af tungmetalioner fra vandige oploesninger
IT1213330B (it) * 1986-08-28 1989-12-20 Rol Spa Tensioattivi derivati da idrossiacidi bi- o tri-carbossilici.
IT1219587B (it) * 1988-05-13 1990-05-18 Fidia Farmaceutici Polisaccaridi carbossiilici autoreticolati
JP4414670B2 (ja) * 2003-04-10 2010-02-10 松谷化学工業株式会社 イオン交換能力を有するグルコースポリマーの製造法及びそれを含有する組成物
DE102004054842A1 (de) * 2004-11-12 2006-05-24 Cognis Ip Management Gmbh Ölhaltige Tensidgele

Also Published As

Publication number Publication date
EP2094734B9 (en) 2010-12-22
WO2008081257A2 (en) 2008-07-10
CA2673953A1 (en) 2008-07-10
US8629252B2 (en) 2014-01-14
US20100311687A1 (en) 2010-12-09
AU2007341080A1 (en) 2008-07-10
WO2008081257A3 (en) 2008-08-28
JP5372774B2 (ja) 2013-12-18
SI2094734T1 (sl) 2010-12-31
PT2094734E (pt) 2010-10-12
EP2094734B1 (en) 2010-09-15
ATE481425T1 (de) 2010-10-15
EP2094734A2 (en) 2009-09-02
JP2010514879A (ja) 2010-05-06
PL2094734T3 (pl) 2011-03-31
EP1939219A1 (en) 2008-07-02
DE602007009306D1 (de) 2010-10-28
ES2348215T3 (es) 2010-12-01

Similar Documents

Publication Publication Date Title
ATE481425T1 (de) Mit citronensäure derivatisierte polysaccharide
ZA200804218B (en) Process for the manufacture of epoxybutanol intermediates
AR110313A2 (es) Derivados de tiazol-2-il-pirrolidina
IL191935A (en) The water-soluble benzozepine compound @ and its @pharmaceutical @ preparation
BR0207983A (pt) Inibidores de metaloproteinase
HRP20110425T1 (en) Process for preparing oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone
CY1111671T1 (el) Ετεροκυκλικη ενωση
EP1568699A4 (en) 1,3-DIHYDROIMIDAZOLE CONNECTION WITH CONDENSED RING
WO2004035718A3 (de) Zusammensetzung
WO2008140099A1 (ja) テトラゾイルオキシム誘導体および植物病害防除剤
DE602006020883D1 (de) Haftklebemittelzusammensetzung auf acrylatbasis
MY155733A (en) Early strengthening agent for hydraulic composition
BRPI0609496C1 (pt) derivado do éster do ácido propiônico
TW200714575A (en) Polyarylene and process for producing the same
DE69920923D1 (de) Anthranilsäurederivate
DK1690832T3 (da) Harpikssammensætning indeholdende calciumhydroxid og legemer formet deraf
EP1605078A4 (en) NEW IMIDAZOL CONNECTION AND USE THEREOF
MY155903A (en) Antitumor agent
TWI339659B (en) Aqueous composition comprising thiazole derivative
WO2005000261A8 (en) Mouth rinse compositions containing n-acyl-arginine alkyl ester salts
WO2009022540A1 (ja) 化合物及び感放射線性組成物
ATE420068T1 (de) Reverse hydroxamsäurederivate
EP1607395A4 (en) PROCESS FOR THE PREPARATION OF SULFOXID DERIVATIVES OR SALTS OF IT IN THE AMORPHIC CONDITION
ATE345346T1 (de) Herstellungsverfahren für 3-sulfonyloxy-3-cephem verbindungen
TNSN08521A1 (en) Phenylpentadienoyl derivatives and their use as par 1 antagonists